Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples